Can I read Pharmaxis PXS Development Update 2023 on EtoBox?

Pharmaxis PXS Development Update 2023 by Origenes Barranquilla is a document available to read on EtoBox.

What is Pharmaxis PXS Development Update 2023 about?

Pharmaxis (PXS) has reported promising proof of concept data for its PXS-6302 skin scar treatment, which reduced excess collagen by up to 50%. The company plans to advance both PXS-6302 and PXS-5505 into further trials, with significant updates expected in the coming months. PXS currently has a market capitalization of $34 million and $14.7 million in cash as of March 31, 2023.

Author

Origenes Barranquilla

Language

EN